MedPath

A study to see the effects of two drugs metronidazole and tacrolimus steroid induced rosacea.

Not Applicable
Conditions
Health Condition 1: L99- Other disorders of skin and subcutaneous tissue in diseases classified elsewhere
Registration Number
CTRI/2020/06/025629
Lead Sponsor
Government medical collage Haldwani
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1.Patients of either sex with steroid induced rosacea.

2.Age 18 years and above.

Exclusion Criteria

1.Pregnant and Lactating Women.

2.Drug allergy .

3. Children less than 18 years

4.Patients with systemic disease.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
1.To compare the efficacy of 0.75% metronidazole gel and 0.03% tacrolimus cream in steroid induced rosacea.Timepoint: The patients will be followed up on 1st, 3rd, 5th and 8th week
Secondary Outcome Measures
NameTimeMethod
1. To Study the adverse effects of 0.75% metronidazole gel and 0.03% tacrolimus cream. <br/ ><br>2. To study the cost of the therapy. <br/ ><br>Timepoint: The patients will be followed up on 1st, 3rd, 5th and 8th week. <br/ ><br>
© Copyright 2025. All Rights Reserved by MedPath